Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback

Oramed (ORMP) targets a new patient subset after FDA setback. Learn how promising trials may revive its protein oral delivery ...

FDA Approves Omeros' YARTEMLEA(R) -- First and Only Therapy Indicated for TA-TMA

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

7 Certification Programs Under $5K That Could Lead to $80K+ Jobs

Explore certification programs under $5K that could lead to higher-paying careers, including training details, job options, ...

Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data

Discover why Lyell Immunopharma (LYEL) stock is up 191% YTD. Explore CAR T therapy breakthroughs, trial milestones, and key investment insights.

As Raleigh grows, the city uses AI to rethink traffic management

Raleigh is testing AI-powered traffic cameras to fine-tune signal timing, improve safety, and reduce congestion at busy ...
Jewish Insider

Sen. Blumenthal presses Noem for security grant data, criticizes GOP funding proposal

The Connecticut senator said he was ‘struck by the severely heightened anxiety’ among local leaders about threats to places ...
Alvernia University

Graduate student pursues sports dream thanks to Alvernia's flexible data analytics program

Graduate student pursues sports dream thanks to Alvernia's flexible data analytics program Have a conversation with Lillian ...